Anti-HIV pill just before approval

We are searching data for your request:

Forums and discussions:
Manuals and reference books:
Data from registers:
Wait the end of the search in all databases.
Upon completion, a link will appear to access the found materials.

Pill is said to protect 75 percent of HIV infection

The American Food and Drug Administration (FDA) is currently reviewing the approval of the first anti-HIV pill, the use of which is said to significantly reduce the risk of infection. So far, only condoms have protected against infection with the HIV virus.

New pill is said to reduce the risk of HIV infection by up to 75 percent
AIDS is still one of the curable diseases. In contrast to many other virus-borne diseases, AIDS does not only occur in certain regions but as a pandemic. While great advances in drug therapy have been made thanks to intensive research that may delay the onset of AIDS after HIV infection, a full recovery still seems a long way off.

Now a committee of US experts has issued a recommendation to the FDA for approval of the first anti-HIV pill. The "Truvada" pill, which is produced by the pharmaceutical company Gilead Sciences, is intended to preventively prevent infection with HIV. After the 22 independent experts completed an 11-hour session and further hearings, the majority voted on Thursday for the commercial launch of the anti-HIV pill. While the Commission's recommendation is not binding on the FDA, it generally follows it.

A clinical study showed that "Truvada" reduces the risk of infection in heterosexuals with a seropositive partner by up to 75 percent. The drug is already used with other drugs for the therapy of HIV infections. (ag)

Read on:
How to deal with HIV infections correctly
Tablets are said to reduce HIV infection risk?
30 years of AIDS: still no cure in sight?
Two million young people infected with HIV worldwide
China: Clinics deny AIDS patients
UN warns of rapid spread of AIDS
AIDS: SI virus is considered a precursor to HIV
Why some do not get AIDS despite HIV
AIDS: no fate with correct antibodies?

Image: Gerd Altmann,

Author and source information

Video: A Drug to Prevent HIVs Spread: Truvadas Promises


  1. Bart

    My compliments to the author, brightened up a break at work. Interesting.

  2. Branton

    Thanks for the news! I was just thinking about it! By the way, Happy New Year to all of you;)

  3. Ziyad

    I can not solve.

  4. Etienne

    I apologize for interfering, but I need a little more information.

  5. Z'ev

    By and large, I agree with you. It just seems to some that they definitely need something to stand out from the crowd. And how to stand out is no longer important.

  6. Ze'ev

    I suggest you visit the site, on which there are many articles on this issue.

Write a message

Previous Article

Certain yeast cells are immune to aging

Next Article

When doctors abuse patient trust